NDC 51267-890
ContraveExtended-Release 8 mg / 90 mg tablet, extended release
On the label: Nalpropion Pharmaceuticals LLC.
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Nalpropion Pharmaceuticals LLC names for other drugs.
Recalls
- Oct 5, 2018 · Class III · Orexigen Therapeutics, Inc.
Container packaging defect.
Lots: Lot #: ZYCY, Exp. 04/11/2021 - Aug 9, 2018 · Class III · Orexigen Therapeutics, Inc.
Defective Container: Customer complaints of punctures in the bottle.
Lots: Lot #: ZCXM, Exp 01NOV2020; ZCXN, Exp 02NOV2020; ZCXP, Exp 09NOV2020; ZCXS, 10NOV2020; ZCXT, Exp 13NOV2020; and ZCXV, Exp 17NOV2020
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Bupropion and Naltrexone: every company that makes it
- Form
- tablet, extended release, oral
- Strength
- 8 mg / 90 mg
- Approval
- NDA NDA200063
- On the market since
- Oct 22, 2014
- Package NDCs
51267-890-0751267-890-99- Official label
- DailyMed (National Library of Medicine), updated Nov 10, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?